These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 8792416)
1. Biomaterials science at a crossroads: are current product liability laws in the United States hampering innovation and the development of safer medical implants? Kohn J Pharm Res; 1996 Jun; 13(6):815-9. PubMed ID: 8792416 [No Abstract] [Full Text] [Related]
2. Patent issue: supplier liability in medical implants and devices: the "Biomaterials Access Assurance Act". Pabst PL; Mills KV Tissue Eng; 2000 Apr; 6(2):189-90. PubMed ID: 10941213 [No Abstract] [Full Text] [Related]
3. The preemptive scope of the Medical Device Amendments of 1976. Sunshine PH Food Drug Law J; 1995; 50(1):191-212. PubMed ID: 10342991 [No Abstract] [Full Text] [Related]
5. Biomaterials availability in the U.S. Galletti PM J Biomed Mater Res; 1996 Nov; 32(3):289-91. PubMed ID: 8897133 [No Abstract] [Full Text] [Related]
6. Effects of products liability on bulk suppliers of biomaterials. Baker FD Food Drug Law J; 1995; 50(3):455-60. PubMed ID: 10343012 [No Abstract] [Full Text] [Related]
7. The medical device industry. Szycher M J Biomater Appl; 1996 Jul; 11(1):76-118. PubMed ID: 8872601 [No Abstract] [Full Text] [Related]
8. The Biomaterials Access Assurance Act of 1998. Walter CF; Richards EP IEEE Eng Med Biol Mag; 1999; 18(2):125-7. PubMed ID: 10101679 [No Abstract] [Full Text] [Related]
9. The forces that threaten the U.S. medical device industry. Benson JS ASAIO J; 1995; 41(3):M238-41. PubMed ID: 8573796 [No Abstract] [Full Text] [Related]
14. The Supreme Court rules on medical device liability--or does it? Richards EP IEEE Eng Med Biol Mag; 1997; 16(1):87-8, 90. PubMed ID: 9058587 [No Abstract] [Full Text] [Related]
15. Junk science v. American competitiveness. Szycher M J Biomater Appl; 1993 Jul; 8(1):3-19. PubMed ID: 8345448 [No Abstract] [Full Text] [Related]
16. The influence of the Product Liability Act, governmental regulation, and medical economics on medical devices and their clinical applications. Hirose TT Artif Organs; 1996 Dec; 20(12):1274-7. PubMed ID: 8947446 [TBL] [Abstract][Full Text] [Related]
17. Biomaterials availability: development of a characterization strategy for interchanging silicone polymers in implantable medical devices. Gould JA; Liebler B; Baier R; Benson J; Boretos J; Callahan T; Canty E; Compton R; Marlowe D; O'Holla R J Biomater Appl; 1993; 4(4):355-8. PubMed ID: 10172007 [No Abstract] [Full Text] [Related]
18. Biological interactions: causes for risks and failures of biomaterials and devices. Jayabalan M J Biomater Appl; 1993 Jul; 8(1):64-71. PubMed ID: 8345450 [TBL] [Abstract][Full Text] [Related]
19. "Safe" biomaterials. Black J J Biomed Mater Res; 1995 Jul; 29(7):791-2. PubMed ID: 7593016 [No Abstract] [Full Text] [Related]
20. The effects of regulation, reimbursement, and product liability on U.S. medical technology innovation. Citron P ASAIO J; 1995; 41(3):M242-4. PubMed ID: 8573797 [No Abstract] [Full Text] [Related] [Next] [New Search]